Medable

Meet the Medable team

Come by booth #204 to talk with one of our enterprise and clinical trial experts.
Executive GM, Customer Value, Medable
Alison Holland
Available to talk about DCT and enterprise solutions.
Executive Director, Business Development
James Thatcher
Available to talk about Medable’s platform solutions. 

Global Adoption of DCTs Panel


Join Medable and key industry leaders in a panel exploring the challenges and solutions for achieving large-scale operations across continents and the extent of study execution fragmentation in global trial models using decentralized clinical trial methods.

Speakers

- Amir Kalali - Moderator
- Alison Holland, Executive GM, Customer Value, Medable
- Kelly McKee (Medidata)
- Noolie Gregory (Syneos)
- Liz Quinlan (CSL Behring)
- Stuart Redding (MRN)
- Shelly Barnes (UCB)

  •  Monday, November 06
  • 10:05 AM EST
  •  15 minutes
NOV

06

Alison Holland
Medable
Executive GM, Customer Value, Medable

Kelly McKee
Medidata
VP DCT

Noolie Gregory
Syneos
VP DCT Operations

Liz Quinlan
CSL Behring
Director, Adaptive Clinical Trial Technology

Deep Evidence Generation and the Modern Clinical Trial


As DCTs and hybrid models reach a maturity point, we're seeing a shift in focus to innovative approaches that can shorten trial activation timelines and overall trial life cycle times while maintaining quality and patient choice.

- Gaining speed and scalability using digitally available, reusable and repeatable content
- Case examples to speed trial startup and recruitment timelines
- Driving standardization through program-wide design choices in evidence generation

  •  Monday, Nov 06
  •  1:44 PM EST
  •  15 minutes
Alison Holland
Medable
Executive GM, Customer Value, Medable